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Summary: We describe a method for the measurement of protein-bound malondialdehyde with the thiobarbituric
acid reaction in human plasma using second-derivative Spectrophotometry. Calibration was done by spectrum height
measurement from the baseline at 532 nm. The data were compared with those obtained by using conventional
absorbance and fluorimetric measurements. The results were linear from 0.2 to 80 μπιοΙ/1 and the detection limit
was 0.19 μπιοΐ/ΐ. Within-run and between-run precision, evaluated by analysing pooled normal plasma, were 8 and
14% respectively. The method was tested for the influence of bilirubin, haemoglobin, glucose, urea, uric acid,
sucrose and N-acetyl-neuraminic acid which interfered in the colorimetric method but not in the technique proposed
here. The mean (± SD) malondialdehyde concentration determined in 59 healthy blood donors with the new assay
was 0.34 (± 0.14) μιηοΐ/ΐ. This assay procedure could represent an alternative to high-performance liquid chroma-
tography for the measurement of malondialdehyde in biological media.
Introduction
Assay of malondialdehyde is the most commonly used
test for evaluating lipid peroxidation (1). This measure-
ment is based on the reaction of malondialdehyde with
thiobarbituric acid to form a 1 : 2 adduct, which has a
stable pink colour that absorbs maximally at 532 nm or
is fluorescent at 553 nm, usually after extraction into n-
butanol (1—3). The use of the thiobarbituric acid reac-
tion to determine lipid peroxidation in complex biologi-
cal media such as serum and plasma is limited by its
lack of specificity, which can be partly overcome by
modifying the reaction conditions and/or improving the
detection system. Many different substances, including
lipid-derived monofunctional aldehydes, sucrose and
ethanol, readily form adducts with thiobarbituric acid
which contribute to the reaction (1,4, 5). The derivative
Spectrophotometry assay can be used to analyse mix-
tures of chromophores. Its efficiency is a function of the
relative position of the absorbance maxima, and in-
creases with the order of the derivative. Given its high
discriminatory power, derivative Spectrophotometry
overcomes interference by compounds with a broader
spectrum, and its specificity is better than that of con-
ventional analytical Spectrophotometry (6).
With the exception of the method described by Es-
pinosa-Mansilla et al., derivative Spectrophotometry has
not been applied to the measurement of malondialde-
hyde in biological media (7). In this study, we quantified
protein-bound malondialdehyde in plasma by means of
seconds-derivative Spectrophotometry and tested the in-
fluence of various interfering substances commonly
found in plasma.
Materials and Methods
Apparatus
A Uvikon 860 spectrophotometer with a Plotter 800 chart recorder
(Kontron Instrument, Montigny le Bretonneux, France) was used
for absorbance measurements. Fluorescence was measured on a
Perkin-Elmer MPF-3 spectrofluorometer (Perkin-Elmer Instru-
ment, Montigny le Bretonneux, France).
Reagents and standards
Thiobarbituric acid, //-butanol (fluorometric grade) and 1,1,3,3-
tetraethoxypropane were from Sigma Chemical Co (via Coger,
France), and other reagents were from Prolabo (Paris, France).
They were used without further purification. The control serum
was lyophilised Biotrol OS (BioMerieux, Lyon, France) rehydrated
daily according to the manufacturer's instructions.
Samples
Plasma was isolated from blood collected on EDTA tripotassium
salt (Beckton Dickinson Vacutainer® Systems, Grenoble, France)
and centrifuged within 30 min. The samples were kept at 4 °C and
used within 24 hours.
Procedure for determining malondialdehyde
Plasma protein bound malondialdehyde was determined according
to Satoh (3), with the following modifications. Plasma was pre-
pared by centrifugation of whole blood collected on EDTA. Each
determination was performed in duplicate. Protein was precipitated
by adding 2.5 ml of 200 g/1 trichloroacetic acid to 0.5 ml of plasma.
After centrifugation at 1000 g for 10 min, the supernatant was
drawn off and the pellet rinsed with 2.5 ml of acetic acid (100 ml/1
in distilled water). The protein precipitate was resuspended in 2.5
ml of acetic acid, and 3 ml of thiobarbituric acid (2 g/1 in 2 mol/1
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NaiSO^) was added. The reaction mixture was heated in a boiling
water bath for 30 min, then rapidly cooled in an ice bath to stop
the reaction. The chromophore was extracted in 4 ml of/i-butanol,
and the organic supernatant isolated by centrifugation for 10 min
at 3000 g.
Fluorescence and absorbance measurements were performed on n-
butanol extracts. Absorbance measurements were carried out at a
wavelength of 532 nm, with ;?-butanol as the blank in the reference
channel. Derivative spectrophotometry measurements were made
by recording the spectrum of the extract from 400 to 700 nm using
;j-butanol as the blank in the reference channel. The scale expan-
sions for the second-derivative spectrum were selected between
-I- 0.001 and -0.001 units of absorbance per nm2, full scale. The
baseline-measurements method was used at 532 nm for quantita-
tion (6). Fluorimetric measurements were made at 515 nm
^citation) and 553 nm (Xemission). The sample sensitivity was set
at 10, and full scale (100%) was determined from the fluorescence
intensity obtained with the 10 μιηοΐ/ΐ 1,1,3,3-tetraethoxypropane
calibration point.
Calibration was done with a stock solution of 1,1,3,3-tetraethoxy-
propane (1.1 g 1,1,3,3-tetraethoxypropane m 100 ml acetic acid,
100 ml/1). Appropriate dilutions were made to obtain concentra-
tions equivalent to 0.1-10 μηιοΐ/ΐ 1,1,3,3-tetraethoxypropane.
Each calibration point was determined in duplicate. The samples
were heated in a boiling water bath for 30 min. After extraction
with /z-butanol, absorbance or fluorescence were measured as spec-
ified for plasma samples.
The influence of haemoglobin and bilirubin was studied by spiking
pooled normal human EDTA plasma with either a haemolysate or
bilirubin (Lee Scientific Inc., via Coger, France) (8). Five standard
reference materials (glucose, urea, uric acid, sucrose, N-acetyl-neu-
raminic acid, all purchased from Sigma were added to EDTA
plasma in order to test their influence on the malondialdehyde de-·
termination. Plasma protein bound malondialdehyde was also de-
termined in 56 healthy subjects and 19 hyperlipoproteinaemic sub-
jects (9 with type Ila and 10 with type lib according to Fred-
rickson) who gave informed consent to the study, and 42 patients
presenting with jaundice.
Statistical evaluation of the data was carried out on a computer
(Apple Macintosh), using Statview II software (Abacus Concept®).
Student t-test was used to estimate differences between data from
patients and controls. The threshold of statistical significance was
p < 0.05.
Results
Calibration was carried out by constructing a standard
curve for the second derivative at 532 nm with 9 sam-
ples containing a 1,1,3,3-tetraethoxypropane standard at
concentrations ranging from 0 to 10 μιηοΐ/ΐ. The regres-
sion equation and the correlation coefficient were as fol-
lows: y = 5.982 x + 0.791 (y = signal height at 432 nm
(in mm); χ = 1,1,3,3-tetraethoxypropane in μηιοΐ/ΐ),
r = 0.998.
The detection limit was 0.19 μηιοΐ/ΐ. Inter-assay
precision of the calibration curves was determined
(n = 34) on six 1,1,3,3-tetraethoxypropane samples con-
taining 0.25, 0.50, 1.00, 2.50, 5.00 and 10.00 μιηοΐ/l
1,1,3,3-tetraethoxypropane. The height values (mean
± SD) expressed in mm were 2.28 ± 0.29,4.01 ± 0.36,
7.00 ± 0.37, 15.86 ± 0.41, 30.89 ± 0.47, 60.48 ± 0.61
with CVs of 7.8%, 8.9%, 5.3%, 2.6%, 1.5% and 1.0%
respectively. Linearity was tested in the range of 0 to
100 μηιοΐ/ΐ using the baseline measurement at 532 nm.
The assay remained linear up to at least 50 μηιοΐ/ΐ of
1,1,3,3-tetraethoxypropane (r = 0.999, ρ < 0.0002). In-
ter-assay precision was determined by analysing the
Biotrol OS control in each run. A mean value of 1.70
(SD =0.11) μπιοΐ/ΐ and a CV of 6% (range 1.52-1.96
μτηοΐ/l) was found. Measurements of 1,1,3,3-tetraeth-
oxypropane standard samples (n = 29) gave a run-to-
run coefficient of variation for the slopes of the calibra-
tion curve of 2.2%. Within-run and between-run
precision, evaluated by analysing pooled normal plasma,
was 8 and 14% respectively. Values of protein-bound
malondialdehyde obtained by the proposed method (x)
and fluorometric assay (y) were strongly correlated:
y = -0.031 + 1.179 x; r = 0.991; p < 0.001; n = 35.
Values determined in 56 healthy subjects with the pro-
posed method were 0.33 ± 0.14 μιηοΐ/ΐ (range 0.12-
0.78 μηιοΙ/1), and with fluorometric assay 1.03 ±0.11
(range 0.84-1.00 μπιοΐ/ΐ).
Bilirubin and haemoglobin interferences were studied by
spiking plasma with increasing concentrations. As
shown in figure 1, a single absorbance measurement car-
ried out at 532 nm yielded falsely enhanced protein-
bound malondialdehyde concentrations. The use of se-
cond derivative spectrophotometry cancelled these influ-
ences, since plasma-, bilirubin- and haemoglobin-spiked
plasma exhibited the same second-derivative spectra
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Fig. 1 Conventional spectra of malondialdehyde (0.30 μιηοΐ/ΐ)
(a), unspiked plasma (malondialdehyde concentration = 0.50
μιηοΐ/ΐ) (b), haemoglobin-spiked plasma (haemoglobin concentra-
tion = 125 μιηοΐ/ΐ) (c) and bilirubin-spiked plasma (total bilirubin
concentration = 50 μπιοΐ/ΐ) (d) obtained after reaction with thio-
barbituric acid.
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Fig. 2 Second derivative spectra of malondialdehyde (0.30
μιηοΐ/ΐ) (a), unspiked plasma (malondialdehyde concentration
= 0.50 μτηοΐ/ΐ) (b), haemoglobin-spiked plasma (haemoglobin
concentration = 125 μπκ>1/1) (c) and bilirubin-spiked plasma (total
bilirubin concentration = 50 μηιοΐ/ΐ) (d) obtained after reaction
with thiobarbituric acid.
(fig. 2). No net influence was found when measurements
were made with fluorescence or derivative spectropho-
tometry, even when high bilirubin or haemoglobin con-
centrations were used. In contrast, absorbance measure-
ments at a single wavelength showed false positive in-
terference by bilirubin or haemoglobin which increased
with concentration (fig. 3).
These results were confirmed by determining the appar-
ent plasma protein-bound malondialdehyde concentra-
tion by the absorbance method and the proposed method
in 52 samples from 42 patients with jaundice. Figure 4
shows the relation between the total bilirubin concentra-
tion and the apparent plasma protein-bound malondial-
dehyde concentration. Total bilirubin (x) and malondial-
dehyde values did not correlate in the derivative spectro-
photometry method (n = 52; r = 0.071; p = 0.61),
whereas a strong correlation existed when absorbance
was only measured at 532 nm: y = 1.3473 + 0.0574 x;
n = 52; r = 0.877; p < 0.001.
Plasma spiked with glucose, sucrose, urea, uric acid and
N-acetyl-neuraminic acid at the final concentrations
listed in the table 1, had no influence on malondialde-
hyde concentrations calculated from derivative spectro-
photometric values.
The proposed method was applied to the study of lipid
peroxidation in patients with type II hyperlipoproteinae-
mia (tab. 2). A significant increase of protein bound ma-
londialdehyde was found in hyperlipoproteinaemia type
lib patients. No influence of sex or age on protein bound
malondialdehyde levels could be demonstrated. Protein
bound malondialdehyde determined with the proposed
method was correlated neither with lipid (total chole-
sterol, triacylglycerols) nor apolipoprotein concentra-
tions (apolipoprotein A-I, apolipoprotein B).
Discussion
Malondialdehyde assay after reaction with thiobarbituric
acid is the most commonly used method for assessing
lipid peroxidation in biological samples. Apparent ma-
londialdehyde concentrations determined in complex
media such as plasma have three different origins. The
first is malondialdehyde already present in the sample.
The second is aldehydes, which can react with thiobarbi-
turic acid to give so-called "thiobarbituric acid reactant
substances". These compounds originate from either
biological markers of lipid peroxidation or oxidation of
polyunsaturated fatty acids in vitro. The third is biologi-
cal substances and xenobiotics that can interfere with
40
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Fig. 3 Influence of bilirubin (a) and haemoglobin (b) on the ap-
parent malondialdehyde concentration. Data are means of three ex-
periments. The apparent malondialdehyde concentration (μπιοΐ/ΐ)
was calculated as the difference between the values of each spiked
sample and that obtained without spiking:
0 100 200 300
Haemoglobin [umol/l]
1: single absorbance determination at 532 nm.
2: fluorometric determination.
3: derivative spectrophotometry determination.
400
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thiobarbituric acid assays (1). We propose here an assay
of protein-bound malondialdehyde which avoids most
interferences by using derivative spectrophotometry.
Accurate malondialdehyde assay must avoid polyunsat-
urated fatty acids oxidation and malondialdehyde forma-
tion in vitro. Since the clot formation and the presence
150 200
Total bilirubin [μιηοΐ/lj
Fig. 4 Values of malondialdehyde in subjects with jaundice. Cor-
relations between total bilirubin concentration (x) and apparent ma-
londialdehyde concentrations (y) calculated from absorbance at 532
nm (+) and derivative spectrophotometry (^). Total bilirubin and
apparent malondialdehyde values did not correlate in derivative
spectrophotometry, whereas there was a significant correlation in
single absorbance measurements.
Tab. 1 Test for interference in the derivative spectrophotometric
assay for plasma malondialdehyde. Plasma samples were spiked
with the indicated concentrations.
Substances Concentration added per litre
Urea
Glucose
Sucrose
Uric acid
N-Acetyl-neuraminic acid
32 mmol/1
20 mmol/1
10 mmol/1
1000 μηιοΐ/ΐ
500 μτηοΐ/ΐ
of metal ions favours malondialdehyde formation, col-
lection of blood on anticoagulants and on chelators is
mandatory (9-12). According to Carbonneau et al.
(13), malondialdehyde in plasma is mostly bound to pro-
teins (83%), a result consistent with those ofHackett et
al. (14) and Lepage et al. (15) who found a low recovery
from free malondialdehyde added to plasma, and those
of Largilliere & Μέΐαηςοη who were unable to find free
malondialdehyde within plasma samples using a HPLC
method (16).
In the proposed method, the malondialdehyde-thiobarbi-
turic acid adduct is determined in the infranatant ob-
tained after precipitation of protein, and absorbances are
measured on the w-butanol extract. The use of acidic pH
allows protein precipitation and elimination of water-
soluble interferents, as well as the thiobarbituric acid
reaction with aldehydes which is completed at a pH near
3 (3, 17). We were unable to realize the malondialde-
hyde assay without previous precipitation of plasma or
without using acidic pH (data not shown).
We confirmed, as previously reported by Satoh, that pre-
cipitation with trichloroacetic acid significantly dimin-
ished influences from water-soluble interferents includ-
ing N-acetyl-neuraminic acid (3), but not haemoglobin
and albumin-bound bilirubin which are found almost en-
tirely in the acidic precipitate. When the plasma haemo-
globin concentration is increased to 175 mg/1 by the ad-
dition of a haemolysate, the apparent lipoperoxide con-
centration is increased 2- to 4-fold, a result consistent
with the data reported here (18). Furthermore, since pa-
tients with liver failure are often jaundiced, the determi-
nation of plasma lipid peroxides needs to be free from
bilirubin interference (19-21).
With conventional absorbance measurements at a single
wavelength, haemoglobin and bilirubin interfere with
the malondialdehyde determination because the spectra
overlap. Derivative spectrophotometry separates peaks
since the absorbance maxima of haemoglobin and biliru-
bin are different from that of malondialdehyde after re-
Tab. 2 Plasma lipid, apolipoprotein and protein-bound malondialdehyde levels in patients with type
Ila and lib hyperlipoproteinaemia.
Quantities Controls
(n = 11)
Patients
Hyperlipoproteinaemia
type Ila
(n = 9)
Significantly different from controls: a ρ < 0.05; b ρ < 0.01; c ρ < 0.001.
Hyperlipoproteinaemia
type lib
(n = 10) -
Total cholesterol (mmol/1)
Triacylglycerols (mmol/1)
Apolipoprotein A-I (g/1)
Apolipoprotein B (g/l)
Apolipoprotein C-II (mg/1)
Apolipoprotein C-II I (mg/1)
Apolipoprotein E (mg/1)
Protein-bound malondialdehyde (μπιοΐ/ΐ)
4.67 ± 0.49
0.78 ± 0.26
1.34 ±0.16
1.00 ±0.20
34 ± 10
84 ±22
42 ±8
0.27 ±0.12
10.06 ± 2.41C
1.03 ±0.41
1.35 ± 0.28
2.26 ± 0.62C
49 ± 17
120 ± 26a
71 ±21b
0.35 ± 0.22
7.56 ± 1.13C
3.16 ± 0.98C
1.31 ±0.29
1.65±0.50b
102 ± 21°
260 ± 80C
92 ± 33b
0.56 ± 0.22a
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action with thiobarbituric acid. This is also true for
the other compounds listed in the table 1. Application
of derivative spectrophotometry to plasma malondial-
dehyde measurement was first published by Espinosa-
Mansilla et al. who used acetonitrile to precipitate
plasma proteins and used the first-derivative of the
absorbance spectrum for quantification (7). The present
report confirms these results and demonstrates that
protein-bound interferents in the thiobarbituric acid test
can be eliminated by derivative spectrophotometry.
Oxidative stress occurs in various human diseases, and
modifications of low-density lipoprotein by free radicals
are supposed to play a role in atherogenesis (22). How-
ever, conflicting blood concentrations of malondialde-
hyde or thiobarbituric acid reactant substances in pa-
tients with high prevalence of atherosclerosis have been
reported (9, 23). We demonstrated in this study that pro-
tein-bound malondialdehyde concentrations were
increased in patients with type lib hypercholesterolae-
mia. Different authors have found significant corre-
lations between lipid and thiobarbituric acid reactant
substances levels. For example, Moving et al., using an
HPLC method for determining blood malondialdehyde
concentration, demonstrated a relationship between ma-
londialdehyde and lipids (e.g.: triacylglycerol and cho-
lesterol levels) respectively, whereas hrvall et al. sug-
gested that blood fatty acid composition influences ma-
londialdehyde levels (24, 25). In our study, no correla-
tion could be found either with normal or
hyperlipoproteinaemic patients, a result consistent with
those of Plachta et.al. who failed to demonstrate a sig-
nificant correlation between lipid and lipid peroxide
levels, determined by Xzgfs method (23). More results
are needed before suggesting that the derivative spectro-
photometric method is more specific than classical thio-
barbituric acid reactant substances tests, on the basis that
avoids the influence of plasma lipid on malondialde-
hyde levels.
The measured mean lipid peroxide concentrations in
the plasma of healthy subjects are lower when HPLC
techniques are used (reviewed 1. c. (26)). This is due to
the separation of thiobarbituric acid-malondialdehyde
adducts from contaminants which absorb or fluores-
cence at the same wavelengths as malondialdehyde.
Reported malondialdehyde concentrations in blood
range from 0.6 to 4.9 μπιοΐ/ΐ, but values are far lower
with HPLC methods (12, 27, 28). The malondialde-
hyde protein-bound values found in this study were
also very low, in the range of HPLC values, suggest-
ing that the derivative spectrophotometry assay may
be as specific as HPLC.
Conclusion
Finally, our results also confirm that malondialdehyde
cannot properly be measured in plasma by classical
spectrophotometric methods. The proposed procedure
represents an alternative to HPLC as proposed by Es-
pinosa-Mansilla et al. (7) and can be used to measure
protein-bound malondialdehyde in plasma samples con-
taining high concentrations of bilirubin, haemoglobin
and other interfering substances.
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